Connor, Clark & Lunn Investment Management (CC&L)’s Unity Biotechnology UBX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,204
| Closed | -$64K | – | 1437 |
|
|
2022
Q3 | $64K | Buy |
+16,204
| New | +$64K | ﹤0.01% | 1056 |
|
|
2022
Q2 | – | Sell |
-3,392
| Closed | -$38K | – | 1208 |
|
|
2022
Q1 | $38K | Sell |
3,392
-6,036
| -64% | -$67.6K | ﹤0.01% | 1006 |
|
|
2021
Q4 | $138K | Buy |
+9,428
| New | +$138K | ﹤0.01% | 1009 |
|